Work

A regulatory T cell signature provides a shared molecular basis for the therapeutic window of opportunity in rheumatic disease

Year: 2026
Type: preprint
Study design: Observational Study
Abstract: ABSTRACT Rheumatic diseases, including rheumatoid arthritis (RA), spondyloarthritis (SpA) and osteoarthritis (OA), show distinct phenotypes yet respond to overlapping therapies, implicating shared immune mechanisms. In the Trans i mmunom cohort, we profiled peripheral blood from 240 individuals (47 healthy, 44 OA, 91 RA, 58 SpA) across deep immunophenotyping, immunoproteomics and Treg-Teff transcriptomics. Single-layer analyses revealed broader Treg than Teff remodeling, along with a shared pattern of reduced activated Tregs and expanded Helios⁺ Tregs across all diseases, alongside a decrease in functional Treg subpopulations, including CTLA4⁺ and CD45RA⁻ Tregs. In RA specifically, LAG3⁺ Tregs were also expanded. Combining omics layers outperformed single-layer approaches for disease classification. Among individual layers, Treg transcriptomes were most discriminative, and integration uncovered disease-specific programs. Unsupervised clustering identified a cross-disease cluster independent of activity, treatment and age, mapping to early disease (≤2 years) and dominated by a Treg dysfunction-associated program. These results provide a biological rationale for the therapeutic “window of opportunity” concept and duration-stratified Treg-directed trials.
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W7214670704
Cites:
Cited by:
Related to: 10